President and CEO, LEO Pharma A/S
| Role | Organisation | Sources |
|---|---|---|
| President and CEO | LEO Pharma A/S | GBS Ventures (12 Nov 2009), GBS Ventures (3 Sep 2009) |
Stories naming Gitte Aabo. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
LEO Pharma's acquisition of Peplin is done, a deal agreed in September 2009 for about US$287.5 million. Peplin continues as a LEO subsidiary led by chief executive George Mahaffey, keeping Australian operations.
Also GBS Ventures
LEO Pharma has struck a deal to buy ASX-listed Peplin for roughly US$287.5 million, with its two biggest shareholders, including GBS Venture Partners, backing the transaction.
Also GBS Ventures